Home › Trial NCT00389389
Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors
- Trial IDNCT00389389
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorAstraZeneca
- Enrollment75
- Start date2006-09
- ConditionsNeoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.